Biohaven Ltd. (BHVN)
NYSE·Healthcare·Biotechnology
$9.60
+0.05%
Mkt Cap $1.11B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | $400.00K | — | — | -$1.22 | -$1.21 | +0.82% | — | — |
| Q4 2025 Nov 10, 2025 | $375.09K | — | — | -$1.91 | -$1.64 | +14.14% | — | — |
| Q3 2025 Aug 11, 2025 | $412.60K | — | — | -$1.94 | -$1.94 | +0.00% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$1.67 | -$2.17 | -29.94% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$1.56 | -$1.85 | -18.59% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$1.70 | -$1.70 | +0.00% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$1.72 | -$3.64 | -111.63% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$1.50 | -$2.20 | -46.67% | — | — |
| Q1 2024 Feb 29, 2024 | — | — | — | -$1.41 | -$1.81 | -28.37% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$1.33 | -$1.50 | -12.78% | — | — |
| Q3 2023 Jul 31, 2023 | — | — | — | -$1.24 | -$1.32 | -6.45% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$1.39 | -$1.03 | +25.90% | — | — |
| Q1 2023 Mar 23, 2023 | — | $215.08M | — | -$1.24 | -$3.32 | -167.74% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$2.53 | -$1.75 | +30.83% | — | — |
| Q3 2022 Aug 5, 2022 | — | $215.08M | — | -$2.79 | -$6.21 | -122.58% | — | — |
| Q2 2022 May 10, 2022 | — | $318.85M | — | -$2.52 | -$2.97 | -17.86% | — | — |
| Q1 2022 Feb 25, 2022 | — | $190.01M | — | -$2.07 | -$3.01 | -45.41% | — | — |
| Q4 2021 Nov 9, 2021 | — | $135.74M | — | -$2.44 | -$2.63 | -7.79% | — | — |
| Q3 2021 Aug 9, 2021 | — | $92.93M | — | -$2.77 | -$3.23 | -16.61% | — | — |
| Q2 2021 May 10, 2021 | — | $43.82M | — | -$2.92 | -$4.21 | -44.18% | — | — |